Strengthening Existing National Organizations Serving Racial and Ethnic Populations Capacity Development Programs: Strategies To Advance Program Implementation, Coordination, Management, and Evaluation Efforts; Notice of Availability of Funds-Amendment, 46525-46526 [05-15796]

Download as PDF Federal Register / Vol. 70, No. 153 / Wednesday, August 10, 2005 / Notices from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 6, 2005. A. Federal Reserve Bank of Richmond (A. Linwood Gill, III, Vice President) 701 East Byrd Street, Richmond, Virginia 23261-4528: 1. Millennium Bankshares Corporation, Reston, Virginia; to acquire 100 percent of the voting shares of Albemarle First Bank, Charlottesville, Virginia, and MB Interim Bank, Charlottesville, Virginia. B. Federal Reserve Bank of Kansas City (Donna J. Ward, Assistant Vice President) 925 Grand Avenue, Kansas City, Missouri 64198-0001: 1. Peak Banks of Colorado, Inc., Nederland, Colorado; to acquire 100 percent of the voting shares of Clear Creek Bank Corp., and thereby indirectly acquire voting shares of First State Bank, both of Idaho Springs, Colorado. Board of Governors of the Federal Reserve System, August 4, 2005. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 05–15772 Filed 8–9–05; 8:45 am] BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM Federal Open Market Committee; Domestic Policy Directive of June 29– 30, 2005 In accordance with § 271.25 of its rules regarding availability of information (12 CFR part 271), there is set forth below the domestic policy directive issued by the Federal Open Market Committee at its meeting held on June 29–30, 2005.1 The Federal Open Market Committee seeks monetary and financial conditions that will foster price stability and promote sustainable growth in output. To further its long-run objectives, the Committee in the immediate future seeks conditions in reserve markets consistent with increasing the federal funds rate to an average of around 31⁄4 percent. The vote encompassed approval of the paragraph below for inclusion in the 1 Copies of the Minutes of the Federal Open Market Committee Meeting on June 29–30, 2005, which includes the domestic policy directive issued at the meeting, are available upon request to the Board of Governors of the Federal Reserve System, Washington, DC 20551. The minutes are published in the Federal Reserve Bulletin and in the Board’s annual report. VerDate jul<14>2003 15:02 Aug 09, 2005 Jkt 205001 statement to be released shortly after the meeting: The Committee perceives that, with appropriate monetary policy action, the upside and downside risks to the attainment of both sustainable growth and price stability should be kept roughly equal. With underlying inflation expected to be contained, the Committee believes that policy accommodation can be removed at a pace that is likely to be measured. Nonetheless, the Committee will respond to changes in economic prospects as needed to fulfill its obligation to maintain price stability. 46525 This action is taken pursuant to the HHS nonprocurement debarment and suspension regulation at 45 CFR part 76. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852. (301) 443–5330. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. 05–15777 Filed 8–9–05; 8:45 am] BILLING CODE 4150–31–P By order of the Federal Open Market Committee, August 2, 2005. Vincent R. Reinhart, Secretary, Federal Open Market Committee. [FR Doc. 05–15793 Filed 8–9–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 6210–01–P [Request for Application (RFA) 05055] DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Scientific Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI), the Acting Assistant Secretary for Health, and the Director, Office of Acquisition Management and Policy, have taken final agency action in the following case: Randall Luce, University at Buffalo, State University of New York: Based on the report of an investigation conducted by the University of Buffalo (UB), State University of New York (SUNY) (UB Report), and a conviction of the criminal offense of grand larceny, as defined in section 110–155.30 of the New York Penal Law, in the Buffalo City Court of Erie County, State of New York (Case #2004ER009612M), the Department of Health and Human Services (HHS) debarred Mr. Randall Luce, former research technician in the UB Research Institute for Addictions (RIA), for a period of three (3) years, beginning on July 26, 2005, and ending on July 25, 2008. Mr. Luce pled guilty to grand larceny and admitted to the misappropriation of funds and the fabrication of research subject interviews in the conduct of an RIA study supported by the United States Public Health Service (PHS), National Institutes of Health (NIH), National Institute on Alcoholism and Alcohol Abuse (NIAAA), grant RO1 AA12452, ‘‘A harm reduction approach for reducing DWI recidivism.’’ PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Strengthening Existing National Organizations Serving Racial and Ethnic Populations Capacity Development Programs: Strategies To Advance Program Implementation, Coordination, Management, and Evaluation Efforts; Notice of Availability of Funds—Amendment A notice announcing the availability of Fiscal Year (FY) 2005 funds to support and strengthen existing National and Regional Minority Organizations (NMOs/RMOs) that engage in health advocacy, promotion, education and preventive healthcare with the intent of improving the health and well-being of racial and ethnic minority populations; published in the Federal Register, on July 26, 2005, Volume 70, Number 142, pages 43152. The notice is amended as follows: On page 43157, second column, please replace the entire paragraph: A special emphasis panel will evaluate complete and responsive applications according to the criteria listed in the ‘‘V.1. Criteria’’ section above. Applications competing for Federal funds receive an objective and independent review performed by a committee of experts qualified by training and experience in particular fields or disciplines related to the program being reviewed. In selecting review committee members for the special emphasis panel, other factors in addition to training and experience may be considered to improve the balance of a panel. Each reviewer is screened to avoid conflicts of interest and is responsible for providing an objective, unbiased evaluation based on the review criteria noted above. The panel provides expert advice on the merits of each application to program officials responsible for final selections for E:\FR\FM\10AUN1.SGM 10AUN1 46526 Federal Register / Vol. 70, No. 153 / Wednesday, August 10, 2005 / Notices awards. Before final award decisions are made, CDC may make pre-decisional site visits to those applicants who rank high on the initial scoring to review the agency’s program, business management, and fiscal capabilities. CDC may also check with the health department, the organization’s board of directors, and community partners to obtain additional information about the organizational structure and the availability of needed services and support. Replace with: An objective review panel will evaluate complete and responsive applications according to the criteria listed in the ‘‘V.1. Criteria’’ section above. The application review will be performed by CDC employees within the agency’s Centers, Institute and Offices but outside the funding office. Dated: August 4, 2005. William P. Nichols, Director, Procurement and Grants Office, Centers for Disease Control and Prevention. [FR Doc. 05–15796 Filed 8–9–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 70 FR 34772–34774, dated June 15, 2005) is amended to reflect the reorganization of the Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Revise the functional statement for the Office of the Chief Science Officer (CAS), as follows: After item (11), insert the following item: (12) monitors vaccine safety and conducts scientific research to evaluate the safety of all currently available and new vaccines. Delete items (5) of the functional statement for the Epidemiology and Surveillance Division (CJ3), National Immunization Program (CJ) and renumber the remaining items accordingly. VerDate jul<14>2003 15:02 Aug 09, 2005 Jkt 205001 Delete the functional statement for the Immunization Safety Branch (CJ37), Epidemiology and Surveillance Division (CJ3), National Immunization Program (CJ) in its entirety. Dated: July 29, 2005. William H. Gimson, Chief Operating Officer, Centers for Disease Control and Prevention (CDC). [FR Doc. 05–15800 Filed 8–9–05; 8:45 am] BILLING CODE 4160–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 70 FR 34772–34774, dated June 15, 2005) is amended to reflect the establishment of the Coordinating Center for Environmental Health and Injury Prevention at the Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: After the mission statement for the Centers for Disease Control and Prevention (C), insert the following: Coordinating Center for Environmental Health and Injury Prevention (CT). The mission of the Coordinating Center for Environment Health and Injury Prevention (CCEHIP) is to plan, direct, and coordinate national and global public health research, programs, and laboratory sciences that improve health and eliminate illness, disability, and/or death caused by injuries or environmental exposures. In carrying out this mission, the CCEHIP (1) promotes mission-related accomplishments across the National Center for Environmental Health (NCEH), Agency for Toxic Substances and Disease Registry (ATSDR) and the National Center for Injury Prevention and Control (NCIPC); (2) fosters excellence in public health science and programs across NCEH, ATSDR and NCIPC; (3) assures the establishment of NCEH, ATSDR and NCIPC priorities and goals and coordinates their alignment with CDC and DHHS priorities and PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 goals; (4) assures that NCEH, ATSDR and NCIPC resources are aligned with their priorities and goals; (5) supports the accomplishment of NCEH, ATSDR and NCIPC goals and priorities; (6) identifies synergies across NCEH, ATSDR and NCIPC and CDC; (7) assures that NCEH, ATSSDR and NCIPC meet statutory and mandated requirements; (8) adheres to best business practices for management and administrative functions across NCEH, ATSDR and NCIPC; and, (9) serves as liaison with CDC Coordinating Centers, Offices, and the Office of the Director. Office of the Director (CTA). (1) Provides leadership and guidance and evaluates the activities of the Coordinating Center for Environmental Health and Injury Prevention (CCEHIP); (2) develops overarching goals and objectives and provides leadership, policy formation, scientific oversight and guidance in program planning and development; (3) coordinates assistance provided by CCEHIP to other CDC components, other Federal, State, and local agencies, the private sector and other nations; (4) provides and coordinates resource management requirements for CCEHIP; (5) develops and provides guidance on workforce development activities within CCEHIP and coordinates the recruitment, assignment, technical supervision, and career development of staff, with emphasis on goals for equal employment opportunity and diversity where appropriate; and, (6) collaborates as appropriate with other Coordinating Centers, Centers, Offices, Institutes of CDC, and other PHS agencies, and other Federal agencies. Dated: July 29, 2005. William H. Gimson, Chief Operating Officer, Centers for Disease Control and Prevention (CDC). [FR Doc. 05–15797 Filed 8–9–05; 8:45 am] BILLING CODE 4160–18–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the statement of Organization, Functions, and Delegations of authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 70 FR 34772–34774, E:\FR\FM\10AUN1.SGM 10AUN1

Agencies

[Federal Register Volume 70, Number 153 (Wednesday, August 10, 2005)]
[Notices]
[Pages 46525-46526]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15796]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Request for Application (RFA) 05055]


Strengthening Existing National Organizations Serving Racial and 
Ethnic Populations Capacity Development Programs: Strategies To Advance 
Program Implementation, Coordination, Management, and Evaluation 
Efforts; Notice of Availability of Funds--Amendment

    A notice announcing the availability of Fiscal Year (FY) 2005 funds 
to support and strengthen existing National and Regional Minority 
Organizations (NMOs/RMOs) that engage in health advocacy, promotion, 
education and preventive healthcare with the intent of improving the 
health and well-being of racial and ethnic minority populations; 
published in the Federal Register, on July 26, 2005, Volume 70, Number 
142, pages 43152.
    The notice is amended as follows: On page 43157, second column, 
please replace the entire paragraph:
    A special emphasis panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above. Applications competing for Federal funds receive an 
objective and independent review performed by a committee of experts 
qualified by training and experience in particular fields or 
disciplines related to the program being reviewed. In selecting review 
committee members for the special emphasis panel, other factors in 
addition to training and experience may be considered to improve the 
balance of a panel. Each reviewer is screened to avoid conflicts of 
interest and is responsible for providing an objective, unbiased 
evaluation based on the review criteria noted above. The panel provides 
expert advice on the merits of each application to program officials 
responsible for final selections for

[[Page 46526]]

awards. Before final award decisions are made, CDC may make pre-
decisional site visits to those applicants who rank high on the initial 
scoring to review the agency's program, business management, and fiscal 
capabilities. CDC may also check with the health department, the 
organization's board of directors, and community partners to obtain 
additional information about the organizational structure and the 
availability of needed services and support. Replace with:
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above. The application review will be performed by CDC 
employees within the agency's Centers, Institute and Offices but 
outside the funding office.

    Dated: August 4, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-15796 Filed 8-9-05; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.